Background Increased body mass index (BMI) is known to be related to ischaemic heart disease (IHD) in populations where many are overweight (BMI > 25 kg/m 2 ) or obese (BMI > 30). Substantial uncertainty remains, however, about the relationship between BMI and IHD in populations with lower BMI levels.
Introduction
In populations, such as those in Europe and North America in which overweight and obesity is common, many prospective observational studies have investigated the associations between body fatness and the risk of ischaemic heart disease (IHD). For these investigations, body mass index [BMI: weight in kilogrammes divided by the square of height in metres, (kg/m 2 )] has generally been used as an indirect but useful measure of adiposity, even though additional information is provided by other indices (such as waist and hip circumference, or subscapular skinfold thickness). Most of these studies [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] are consistent in demonstrating a strong positive association between BMI and the risk of IHD, at least among individuals with BMI . 20 kg/m 2 at the start of the follow-up. Even within this range, however, questions remain about the magnitude of the risk associated with BMI in various different circumstances (e.g. at different ages, in different populations, and at different levels of other risk factors). 12 Moreover, below this range, there is substantial uncertainty about not only the strength but also the direction of the relationship. For, in Western populations, the proportion of apparently healthy adults who have BMI , 20 kg/m 2 is relatively small, and the Western studies did not separately record enough events at these lower levels of BMI to determine the shape of the association reliably. 1, [4] [5] [6] 10, 11 To address these issues, large prospective studies involving at least a few thousand events are needed in leaner populations. 13, 14 We report a prospective study of the association between BMI and IHD mortality in a nationally representative cohort of .220 000 Chinese men with mean BMI 21.7 kg/m 2 when the study started in 1990-91, whose mortality has been followed-up for 10 years.
Subjects and methods

Baseline survey
The study design, field survey methods, and participants have been described elsewhere. 15 Briefly, 45 areas throughout China were chosen at random from the 145 nationally representative Disease Surveillance Points (DSP) for a large national prospective study of the correlates of adult mortality. The Chinese DSP system, which covers~1% of the population, was established during the 1980s by the Chinese Centre for Disease Control and Prevention (CDC: formerly the Chinese Academy of Preventive Medicine) to provide mortality statistics on both communicable and non-communicable disease for the entire country. 16, 17 A typical surveillance point covers a defined population of 50 000-100 000 residents in 4-8 geographically defined units (urban street committees or groups of rural villages). During 1990-91, all men aged .40 years in two or three randomly selected units from each of the 45 selected DSP sites were invited to participate in the survey. About 80% of those invited did participate, and the present report is of 10 year follow-up to January 1, 2002 among the 222 246 men aged 40-79 at the start of the study.
Health screening clinics were set up in each of the study areas, and all study participants were interviewed by trained health workers using a standardized questionnaire. Information obtained at the initial baseline survey included education, occupation, smoking habits, alcohol consumption, tea drinking, current and previous exposure to indoor air pollution (particularly by coal smoke), diet, and medical history. Height, weight, blood pressure, and peak expiratory flow rate were also measured for all participants. The primary factor of interest for the present analysis is BMI, for which data were available for all but 154 study participants (Table 1) . After the baseline survey, no systematic information about weight changes was collected.
Annual follow-up for cause-specific mortality Vital status was monitored on a regular basis by local DSP staff using official death certificates and local residential records. Causes of death were sought chiefly from official death certificates, supplemented (if necessary) by review of selected medical records. The underlying cause of each death was coded centrally, blinded to baseline information, by trained staff in the central DSP office, using the ninth revision of the World Health Organization International Classification of Disease (ICD-9). Nearly all adult deaths in the study areas involved some form of medical attention, and their underlying causes were then certified by a doctor. In rare situations (,5%) when death had occurred at home without prior medical attention, a special investigation with standard procedures was conducted by local DSP staff to determine the probable cause from the symptoms or signs described by the family members. 16, 17 To minimize underreporting of deaths and identify those who had permanently moved out of the study area, active confirmation of vital status for each study participant was also carried out separately once a year through local street committees or the administrators of individual villages.
Statistical analysis
Since it is often difficult to assign reliably underlying causes to deaths at older ages, all analyses are restricted to deaths occurring between ages 40 and 79, with censoring when men reached 80 years of age (or moved away from the original study area).
In case pre-existing vascular disease had caused weight loss, thereby producing a spurious inverse association between BMI and IHD mortality, study participants who reported a history of heart disease or stroke at baseline were excluded from the main analyses. But, because obesity can cause hypertension or diabetes that then predisposes to IHD, these latter conditions (including medication for hypertension) were not used to exclude participants from the main analyses. A stratified Cox proportional hazards model was used with BMI as the exposure variable and IHD death as the outcome. 18 The analyses were stratified by individual area and by age at risk, and were adjusted simultaneously for smoking (current/former/ never) and alcohol drinking in most weeks (yes/no). All study participants were divided into six categories of baseline BMI (with cut-points at 18, 20, 22, 24, and 26 kg/m 2 ) and the hazard ratios for IHD mortality, which are referred to as risk ratios (RRs), were calculated for each category. The 95% confidence interval (CI) for each log RR was estimated using the 'floating absolute risk' method, which facilitates many different comparisons and tests for trend between different BMI categories, rather than ) for each category would be similar to that seen in other studies, and a usual value was derived from the Prospective Studies Collaboration (PSC). 21 Weight and height are, however, easy to measure reliably and tend not to fluctuate substantially over a period of just a few years (the correlation between BMI measurements 5 years apart being 0.90 in the PSC), so the effects of our correction for this bias were only marginal. In addition to the semiparametric analyses described above that plotted disease risk against estimated mean usual BMI in each category, RRs were also calculated by fitting an inverse-variance-weighted regression line through the log RRs for selected BMI categories.
Results
After an average of 10 years of follow-up, 30 040 (13.5%) men had died between the ages of 40 and 79, and 13 832 men had survived to age 80, while 23 834 (10.7%) were known to have been lost to follow-up before age 80 (~1% per annum), mainly because of the demolition of entire residential areas for redevelopment. Those who were lost to follow-up were slightly younger than those who were not (53.1 vs 54.5 years), but had similar age-standardized mean BMI (21.9 vs 21.7 kg/m 2 ), systolic blood pressure (SBP) (123.4 vs 124.2 mm Hg), and prevalence of ever smoking (73.6% vs 73.3%) or of self-reported poor health status (7.2% vs 7.3%). Of the deaths recorded, 10 264 (34%) were attributed to cardiovascular disease (ICD-9 390-459 or 798), including 1942 (6.5%) from IHD (ICD-9 410-414) and 6435 (21.4%) from stroke (ICD-9 430-438). In urban areas the proportion of deaths attributed to IHD was 10.5% (676 deaths), compared with 5.4% (1266 deaths) in rural areas. Of the IHD deaths, 247 deaths occurred among men who had reported a history of heart disease or of stroke at the baseline survey, and are therefore excluded from the main analyses.
Relationship of baseline BMI with other key variables
The overall mean (SD) BMI was 21.7 (2.7) kg/m 2 , decreasing slightly with increasing age (Table 1) , and it was significantly higher among urban men (23.1) than among rural men (21.2) after adjustment for age. By standard WHO criteria, 22 Table 2 shows the relationship of BMI with certain other variables among all men aged 40-79 at baseline, after standardizing for age (mean 54.3 years) and area. BMI was only slightly negatively related to height, whereas it was strongly positively related to body weight. For every 2 kg/m 2 higher BMI, the SBP was on average~3 mm Hg higher. Men with higher BMI tended to be better educated and to have a higher peak expiratory flow rate, with higher proportions consuming alcohol, green tea, meat, fish, and fruit (but not milk). Although smoking was more prevalent among men with low BMI, no apparent association was found among smokers between BMI and the mean amount smoked per day (which means that the dose of tobacco per kg body weight was inversely related to BMI). Participants with lower BMI (especially those with BMI ,18 kg/m 2 ) were more likely to report poor general health, but those with higher BMI were more likely to report diabetes, hypertension, heart disease, and stroke. Table 3 shows the relationship between measured BMI at baseline and the subsequent age-standardized mortality rate from IHD among participants without a prior history of vascular disease reported at baseline. The overall age-standardized IHD mortality rate was 7.7 per 10 000 person years (by contrast with 17.0 among men with pre-existing vascular disease), and there appeared to be a J-shaped association between BMI and IHD mortality (P-value for test of non-linearity across all six groups was 0.017), with a measured BMI in the range 20-21.9 kg/m 2 associated with the lowest risk after adjustment for age, locality, smoking, and alcohol drinking. Above this range, IHD mortality increases steadily with increasing BMI, with RRs of 1.12, 1.29, and 1.44, respectively, in the upper three BMI groups (P-value for trend between four groups ,0.0001). higher baseline BMI was associated with an 8% (95% CI 2-14%, 2P 5 0.013) higher IHD mortality. However, the self-correlation of repeat measurements of SBP is expected to be much lower than the self-correlation of repeat measurements of BMI. In this population, each 3 mm Hg higher baseline SBP was associated with~3.5% (95% CI 2-5%) higher IHD mortality (data available). If the self-correlation of repeat measurements of SBP was about one-half, then the relationship of usual SBP to risk would be about twice as steep as the relationship of a single measurement of SBP to risk. 20 Hence, a 3 mm Hg higher 'usual' SBP would be associated with~7% (95% CI 4-10%) higher IHD mortality. Using this assumed relationship between risk and 'usual' SBP to adjust for blood pressure, the IHD RRs in the BMI range above 20-21.9 kg/m 2 were not significantly different from unity (Table 3) . This 7% increase in risk per 3 mm Hg higher usual SBP is somewhat weaker than that seen in largely European and North American populations (10% higher risk for every 3 mm Hg higher usual SBP), 23 suggesting that there may still be some underestimation of the relevance of usual blood pressure to the relationship between BMI and IHD. Among men with baseline BMI , 20 kg/m 2 , lower BMI was still associated with lower SBP (as well as diastolic BP) but not with lower IHD mortality-indeed, the association with IHD appeared to be reversed. Although the relative risk of death for BMI , 20 kg/m 2 was not significantly greater than that for BMI a Except for mean age and urban locality, all other variables were adjusted for individual area and age by 5 year age group by direct standardization to the study population. b Based on the self-reported prior history of hospital diagnosis. Those with prior heart disease or stroke are excluded from subsequent analyses. consequence of undiagnosed vascular disease (even though participants with a prior history of diagnosed vascular disease were excluded from the analyses), further analyses were carried out after excluding the first 3 years of follow-up, but the same pattern was still observed (Figure 2a) . Likewise, exclusion of men with medication for hypertension or self-reported poor general health status at baseline did not materially alter the excess risk of IHD observed among men with BMI ,20 kg/m 2 , nor did further adjustment for the frequencies of meat, fish, fruit, and vegetable intake (data not shown).
Association of BMI with IHD
In the present study, smoking was associated with a lower BMI and this was adjusted for in all the standard analyses (current/former/never). The amount smoked per smoker was largely unrelated to BMI (Table 2) , so further adjustment for amount smoked made no material difference to the estimated RR. Likewise, a further analysis restricted to those men who reported never having smoked indicated a similar excess risk of IHD among those with BMI , 20 kg/m 2 , though the CIs were wider owing to the relatively small number of IHD cases involved (Figure 2b ).
About 13% of the men had a prior history of chronic obstructive pulmonary disease (COPD) at baseline. Those individuals had a lower baseline value of BMI and a much higher risk of subsequent death from COPD, which includes pulmonary heart disease. To limit the possible effects of any misclassification of pulmonary heart disease (which is relatively prevalent at the low end of the BMI distribution) as IHD, further analyses were conducted after excluding men with prior COPD Figure 3 shows the associations of BMI with risk of IHD death separately for three age (at risk) groups. Among men with BMI .20 kg/m 2 , there was a positive relationship between BMI and IHD risk in all three age groups. In Figure 4 , the proportional effects associated with a 2 kg/m 2 difference in BMI appeared to be stronger at younger ages, although non-significantly (trend c 2 1 5 2.7; P 5 0.1), which perhaps reflects the stronger relationship between blood pressure and IHD risk at younger ages. 23 Similarly, the excess risk of IHD death among men with BMI , 20 kg/m 2 appeared to be more pronounced at younger ages (29, 13 , and 0%, respectively, for men aged 40-59, 60-69, and 70-79; P 5 0.2 for trend), and would become more so after allowing for usual blood pressure. Figure 4 also shows the strength of the association by locality of residence (urban/rural), smoking, alcohol drinking, and height among men with BMI . 20 kg/m 2 . There was little evidence that the association of IHD death with BMI was significantly modified by any of these variables, although the statistical power to detect potentially important modifications is limited.
Associations of BMI with IHD risk in different categories of men
Discussion
This is by far the largest prospective study in China of the association between BMI and mortality from IHD, and it involves a nationally representative population of men. In this study, only 11% of the men were overweight or obese at baseline, by contrast with more than half in the USA or UK at these ages, 24, 25 and throughout the range of BMI levels that were studied BMI was strongly positively related to blood pressure.
Direct association among people with BMI . 20-22 kg/m 2 Among men without known history of vascular disease at baseline, there was a direct and positive association between BMI and IHD mortality that continued down to a BMI of~20-21.9 kg/m 2 . Among men with a BMI above this range, a 2 kg/m 2 higher in usual BMI corresponded on average to 12% higher IHD mortality. These effects, though moderate, appeared to be largely independent of age, smoking, and alcohol drinking, and were similar in urban and rural areas.
It has been suggested that East Asian populations may experience adiposity-related adverse health outcomes at lower BMI levels than Western populations, but these were based largely on cross-sectional or small prospective study data. 26, 27 The results of this prospective study for men with BMI . 20-21.9 kg/m 2 are largely compatible with those from large prospective studies in Western populations. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] They are also consistent with results from other Chinese populations, 13, 14 although none of those studies was nationally representative and, even collectively, they involved far fewer cases of IHD than the present study. In a meta-analysis of prospective studies from the Asia Pacific region, 28 involving just over 2000 non-fatal or fatal IHD (but including only~200 IHD cases from 11 relatively small studies in China), the mean baseline BMI was~24 kg/m 2 and it was positively associated with the risk of IHD (independently of age, smoking, and alcohol), with each 2 kg/m 2 higher BMI again being associated with~12% (95% CI 10-14%) higher IHD risk. In the present study, as well as in these other studies, higher BMI was associated with higher IHD risk not only for people who would conventionally be regarded as overweight but also for many people in the so-called normal range of BMI values (20-25 kg/m 2 ).
22
There continues to be some uncertainty as to how much of these adverse effects of BMI on IHD risk can be accounted for by its adverse effects on blood pressure, blood lipids, and diabetes. [29] [30] [31] [32] [33] [34] In the present study blood lipids were not measured, but about half of the adverse effect of BMI on IHD in the range .20 kg/m 2 could be accounted for by its adverse effect on blood pressure. Other studies have found that BMI is also associated with adverse changes in LDL and HDL cholesterol (and, perhaps less importantly in this population, diabetes) that have not been allowed for in the present analyses. Consequently, the adverse association of higher BMI with IHD risk in the range .20 kg/m 2 can probably be largely or wholly explained by its adverse associations with blood pressure, blood lipids, and diabetes. Figure 1 so that the shape of the association at the low end of the BMI distribution was susceptible to large random fluctuations. The present study involves substantial number of IHD deaths among men whose BMI was ,20 kg/m 2 , thus providing statistically reliable evidence that the relationship does not continue linearly downwards and may even be reversed among those who are underweight.
The main analyses were restricted to those without a prior history of vascular diseases and were adjusted for various other factors, so the observed excess risk of IHD death, in comparison with what would have been extrapolated from linear downwards of the relationship at higher BMI levels, is not accounted for by chance or by prior vascular disease affecting BMI at baseline. This apparent excess risk is not attributable to misclassification of COPD-related pulmonary heart disease, or to residual confounding by smoking. The excess risk of IHD death at BMI , 20 kg/m 2 given usual SBP is unexplained, and it would probably be even more extreme given not only usual blood pressure but also usual levels of blood lipids. It is, however, not necessarily causal. 37 and damage of the myocardial fibres. 38 Some chronic infections may also contribute to the development of IHD, [39] [40] [41] [42] [43] and individuals with extremely low body weight may have reduced immune function, 44, 45 which might predispose them to increased risk of chronic infection. Moreover, severe loss of adipose tissue and its triglyceride storage capacity (as in lipodystrophy) can lead to insulin resistance, diabetes, hyperlipidaemia and fatty liver, which have the effects that are similar to some of those caused by obesity. 46 Finally, in Western studies of acute MI, patients with very low BMI have worse survival in hospital than those with a higher BMI. 47, 48 If this was also the case in Chinese MI patients, then this might help explain the higher IHD mortality associated with very low BMI in this prospective study.
Implications
The present study involves large numbers of IHD deaths, so its findings are statistically reliable. The positive association between BMI and IHD death at BMI levels .20 kg/m 2 can largely or wholly be explained by the association of BMI with blood pressure and, most probably, blood lipids. But, although the association between BMI and blood pressure continues downwards at lower levels of BMI, the risk of IHD death does not continue down linearly-indeed, after adjustment for blood pressure, the risk is somewhat greater for those with BMI , 20 than for those with BMI 5 20-21.9 kg/m 2 . Further epidemiological studies with collection of blood samples, perhaps using additional measures of adiposity (such as waist circumference and bioelectrical impedance [49] [50] [51] , in low BMI populations may help elucidate mechanisms by which extremely low BMI increases the risk of IHD at given levels of blood pressure and blood lipids. The present findings among those with BMI levels .20 kg/m 2 cannot be translated directly into public health conclusions about the relevance of elevated BMI to overall mortality in China, as IHD accounted for only 6.5% of all the deaths in this study, and some non-IHD causes of death are inversely related to BMI. The BMI values associated with minimum overall mortality may vary from population to population, depending on the particular BMI distributions and the background rates of mortality from IHD and other diseases. , the association with IHD risk is reversed, which does not appeared to be caused by confounding or other bias, and became more extreme after allowing for blood pressure.
As IHD accounted for only~7% of all the deaths in the study, the present study findings cannot be translated directly into public health conclusions about the optimal levels of BMI in the population.
